Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer

ClinicalTrials.gov ID: NCT04729608

Public ClinicalTrials.gov record NCT04729608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo/Paclitaxel-Controlled Study of Batiraxcept (AVB-S6-500) in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer (AXLerate-OC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind Phase 3 study to compare the efficacy and safety of batiraxcept (AVB-S6-500) in combination with paclitaxel (PAC) versus placebo in combination with PAC in patients with platinum resistant recurrent ovarian cancer.

Study identification

NCT ID
NCT04729608
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aravive, Inc.
Industry
Enrollment
366 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2021 (Actual)
Primary completion
Aug 4, 2023 (Actual)
Completion
Aug 4, 2023 (Actual)
Last update posted
Oct 30, 2023

2021 – 2023

United States locations

U.S. sites
84
U.S. states
35
U.S. cities
77
Facility City State ZIP Site status
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36604 —
Disney Family Cancer Center Burbank California 91505 —
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 —
UCLA Women's Health Clinical Research Unit Los Angeles California 90095 —
UC Irvine Health-Chao Family Comprehensive Cancer Center Orange California 92868 —
Stanford Women's Cancer Center Palo Alto California 94304 —
University of California, San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 —
Olive View UCLA Medical Center Sylmar California 91342 —
Banner MD Anderson Cancer Center/North Colorado Medical Center Greeley Colorado 80631 —
Hartford Hospital Hartford Connecticut 06106 —
Yale University School of Medicine New Haven Connecticut 06520 —
Baptist MD Anderson Cancer Center Jacksonville Florida 32207 —
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140 —
AdventHealth Gynecologic Oncology Orlando Florida 32804 —
Florida Cancer Specialists West Palm Beach Florida 33401 —
Georgia Cancer Center at Augusta University Augusta Georgia 30912 —
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Southeastern Regional Medical Center, LLC Newnan Georgia 30265 —
Lewis Cancer & Research Pavilion at St. Joseph's/Candler Health System, Inc. Savannah Georgia 31405 —
The University of Chicago Medical Center Chicago Illinois 60637 —
North Shore University Health System Evanston Illinois 60201 —
Dr. Sudarshan K. Sharma, Ltd. Hinsdale Illinois 60521 —
Midwestern Regional Medical Center, LLC Zion Illinois 60099 —
Community Health Network Indianapolis Indiana 46250 —
St Vincent Hospital and Healthcare Center Indianapolis Indiana 46260 —
St. Elizabeth Healthcare Edgewood Kentucky 41017 —
Baptist Health Lexington Lexington Kentucky 40503 —
Women's Cancer Care Covington Louisiana 70433 —
Willis-Knighton Physician Network Shreveport Louisiana 71103 —
Maine Medical Partners - Women's Health - Division of Gynecologic Oncology Scarborough Maine 04074 —
Greater Baltimore Medical Center Baltimore Maryland 21204 —
Holy Cross Hospital Silver Spring Maryland 20910 —
Beth Israel Hospital Boston Massachusetts 02215 —
Dana Farber Cancer Institute (DFCI) Boston Massachusetts 02215 —
Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital South Weymouth Massachusetts 02190 —
Baystate Medical Center Springfield Massachusetts 01199 —
University of Michigan Ann Arbor Michigan 48109 —
Mayo Clinic Rochester Minnesota 55905 —
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Cox Health Springfield Missouri 65807 —
Washington University School of Medicine - Division of Gynecologic Oncology St Louis Missouri 63110 —
Mercy Hospital, David C Pratt Cancer Center St Louis Missouri 63141 —
Billings Clinic Billings Montana 07450 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
Center of Hope Reno Nevada 89511 —
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 —
The Valley Hospital - Luckow Pavilion Paramus New Jersey 07652 —
Holy Name Medical Center Teaneck New Jersey 07666 —
Optimum Clinical Research Group, LLC Albuquerque New Mexico 87109 —
The Blavatnik Family-Chelsea Medical Center at Mount Sinai New York New York 10011 —
North Shore Hematology Oncology Assoc. DBA NY Cancer and Blood Specialists Port Jefferson Station New York 11776 —
University of Rochester Medical Center Rochester New York 14620 —
Stony Brook University Hospital Stony Brook New York 11793-7263 —
Duke Cancer Center Durham North Carolina 27710 —
First Health of the Carolinas Pinehurst North Carolina 28374 —
Gabrail Cancer Center Research Canton Ohio 44718 —
Miami Valley Hospital South Centerville Ohio 45459 —
University of Cincinnati Cincinnati Ohio 45267 —
Ohio State University (OSU) Wexner Medical Center OSU Gynecologic Oncology at Mill Run Columbus Ohio 43210 —
Columbus NCORP Columbus Ohio 43215 —
Kettering Cancer Center Kettering Ohio 45429 —
Stephenson Cancer Center - University of Oklahoma Oklahoma City Oklahoma 73104 —
Oklahoma Cancer Specialists and Research Institute, LLC Tulsa Oklahoma 74146 —
Providence Cancer Institute Franz Clinic Portland Oregon 97213 —
University of Pennsylvania Health System Philadelphia Pennsylvania 19104 —
Magee Women's Hospital of UPMC Pittsburgh Pennsylvania 15213 —
West Penn Hospital Pittsburgh Pennsylvania 15224 —
Abington Memorial Hospital, Hanjani Institute for Gyn Onc Willow Grove Pennsylvania 19090 —
Lankenau Medical Center Wynnewood Pennsylvania 19096 —
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 —
Medical University of South Carolina Charleston South Carolina 29425 —
Sanford Gynecology Oncology Clinic Sioux Falls South Dakota 57104 —
Chattanooga's Program in Women's Oncology Chattanooga Tennessee 37403 —
University of Tennessee Knoxville Tennessee 37920 —
Tennessee Oncology PLLC Nashville Tennessee 37203 —
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Virginia Commonwealth University Richmond Virginia 23298 —
Carilion Clinic Gynecology Oncology Roanoke Virginia 24016 —
Swedish Cancer Institute Seattle Washington 98104 —
Seattle Cancer Care Alliance Seattle Washington 98195 —
West Virginia University Morgantown West Virginia 26506 —
University of Wisconsin Clinical Science Center Madison Wisconsin 53792 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —
Pro Healthcare Waukesha Memorial Hospital Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04729608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04729608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →